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Abstract 
Aims: To investigate the role of Candida albicans TUP1-mediated filamentation in the colonization of the 
mice gut. Material & Methods: We use molecular genetics to generate a strain where filamentation is 
regulated by altering the expression of the TUP1 gene with tetracyclines. Results: The colonization rates 
reached with the TUP1REP-RFPREP strain were lower compared to wild type strain and completely absent 
after induction of filamentation. No differences in the susceptibility to bile salts nor in the adhesion to the 
mouse intestine epithelium was observed. Conclusions: Locking the blockage of C. albicans in a 
filamentous form impedes cells gut colonization in the mouse. 
  
Introduction 
Candida albicans is a pathogenic yeast that causes a wide range of infections, collectively called 
candidiasis. This yeast is part of the microbiota of most humans but depending on the immunological 
status of the host it may lead to systemic diseases on immune deficient individuals that are very severe 
and frequently life-threatening. This yeast is therefore considered an opportunistic pathogen, residing in 
the oral cavity and the gastrointestinal & urogenital tracts of immunocompetent individuals. C. albicans 
pathogenesis is considered to be multifactorial, as there is not a single factor responsible for the virulence 
of this fungus; rather, several components have been shown to be involved in its pathogenicity such as 
metabolic traits, signalling pathways, cell wall architecture and secreted products that make separate local 
and temporal contributions during pathogenesis [1, 2]. The relevance of most of these factors has been 
determined using either in vitro or in vivo models. Among the later, the intravenous systemic infection 
model has been the most widely used in the past for testing virulence determinants in this yeast [3] 
although superficial and mucosal models are clearly relevant considering the pathology of candidiasis [4]. 
The use of commensalism models developed long time ago [5, 6], but only popularized recently [7, 8], is 
enabling the analysis of the contribution of different genes to colonization [9]. 
Several C. albicans factors have been shown to play a role in the adaption to the commensal state during 
gastrointestinal colonization [9, 10]. They comprise epigenetic transitions [11], iron acquisition [12], 
signalling pathways [13] and metabolic traits [14] among others. One important feature of C. albicans is its 
dimorphic nature, the ability (under appropriate stimuli) to develop a yeast to hyphae transition. This 
feature has been related to its ability to cause infections: C. albicans mutants strains that grow only in the 
yeast form were found to be avirulent in the mouse systemic model [15], although mutant strains that only 
grew -or had an enhanced ability to grow- in the filamentous forms were also found to be attenuated in 
virulence [16, 17]. It is now generally accepted that neither of these forms are intrinsically virulent although 
they may play different specialized functions during infection within the host, both temporally and locally.  
Although dimorphism has been mainly studied in the mouse systemic model [18], its role in the mouse 
commensalism model is less documented. An early study made use of an intrinsically filamentous mutant 
(tup1) that revealed reduced colonization in the gut [7]. Also, a recent study using strains locked in the 
filamentous form a similar behaviour [19]. However, both studies suffered from using intrinsically 
filamentous forms of C. albicans, which are difficult to handle in the laboratory due to its hyphal nature 
which does not easily allow standardization of inoculum administration. In addition, as the inoculum is 
administered as a complete hyphal form, and one could argue that hyphi are not deficient in long term 
colonization but only during the early stages that mediate adaptation to the gut cavity [20]. To circumvent 
these caveats and allow a temporal dissection of this process, we have generated a C. albicans mutant 
strain in which filamentation can be triggered by altering TUP1 levels, as deletion of this transcriptional 
regulator lock cells in the filamentous form [21]. Using a filamentation doxycycline regulated strain we 
have determined that induction of filamentation once established in the mouse gut results in the inability to 
colonize the mouse gut and complete loss of the fungus. We have also validated the use of a heat 
inactivated chlortetracycline using functional bioassays, showing its usefulness in in vivo analysis of gene 
expression in this fungus.  
Strains and growth conditions 
The strains used are described in Table 1. Cells were grown at 37ºC in YPD medium (1% yeast extract, 2% 
peptone and 2% dextrose) unless otherwise stated. Chlortetracycline (Sigma-Aldrich) was heat inactivated 
(121º C for 22 min) to obtain aCT (autoclaved ChlorTetracycline) that was used at 1 g/L or 20 mg/L for in 
vivo and in vitro assays respectively. 
The susceptibility/resistance to different compounds was performed through drop test as follows. Cultures 
grown at 37ºC for 16 hours, in the presence or not of aCT, were adjusted to 2x107 cells/mL, serially 10-fold 
diluted and deposited (5 µl) onto solid YPD plates supplemented (or not) with bile salts (Sigma-Aldrich). 
Plates were incubated at 37ºC for 24 hours before scanned.  
Genetic procedures 
To develop a regulated filamentous strain, the ORF of TUP1 was amplified by PCR from the clinical isolate 
SC5314 strain using the primers up-TUP1-myc (GATCTCGAGTATGTATCCCCAACGCACCC) and rev-
TUP1-myc (ATCGCGGCCGCATTTTTTGGTCCATTTCCAAATTC). The 1536 bp PCR product was cloned 
in the intermediate pGEMT plasmid (Promega), digested with Xho I and Not I and accommodated in pNRU-
RFP [22], a doxycycline repressible plasmid, previously digested with Sal I and Not I to generate pNRU-
TUP1, were TUP1 is tagged with the myc epitope. Homologous recombination occurs at the ADH1 locus by 
means of Kpn I-Sac II digestion. Transformation of C. albicans in a tup1 background [21] generated a 
TUP1REP strain. For RFP labeling, we used the pDS2-dTOM2 plasmid, which expresses, together with 
pNRU, express RFP under the control of the TET promoter and recombines at the ARD1 locus by Kpn I 
digestion. It was constructed as follows: the TET promoter (tetO+OP4) was amplified by PCR from pNIM1 
plasmid using the primers TETPR up (CTAGTCGACTTTACCACTCCCTATCAGTGATAGAGAA) and TETPR 
rev (GTAGCTAGCTATTTATATTTGTATGTGTGTAGGAGTTAACG), digested with Sal I and Nhe I and 
introduced in the plasmid pDUM0-L [23], previously digested with Xho I and Nhe I, to generate the pDUM2-
L plasmid. The dTOM2 ORF was amplified with the primers dTOM2 up 
(ACTGCTAGCGAGATGGTTTCTAAAGGTGAAGAATCG) and dTOM2 rev 
(AAGGATCCTCGAGCCCATATTATTATCTTCAGAAGAAGCAGTACC) from pNIM1R-dTOM2 [13], 
digested with Nhe I and BamH I and introduced in pDUM2-L by replacing the CbLUC gene to generate 
pDUM2-dTOM2. Finally, the SAT1 marker was amplified from pNIM1 with the primers SAT1_up 
(ACTTCTAGATGTCTGCAGGACCACCTTTGATTG) and SAT1_rev 
(CTGCCGCGGAGCGTCAAAACTAGAGAATAATAAAGAAAACG), digested with Xba I and Sac II and 
ligated in pDUM2-dTOM2, digested with the same pair of enzymes, replacing the URA3 marker, to generate 
the final pDS2-dTOM2 plasmid. 
Protein extracts and immunoblot analysis 
All procedures involving cell lysis, protein extraction, gel electrophoresis and transfer to nitrocellulose 
membranes were made as previously described [24]. Protein extracts were measured at A280nm to equalize 
the amount of protein loaded for western blot analysis and probed with anti-myc, clone 4A6 (Millipore). 
Western blots were developed according to the manufacturer´s conditions using the Hybond ECL kit 
(Amersham Pharmacia Biotech).  
In vivo fitness assays 
The murine gut colonization assays were performed following the protocol previously described [13]. Briefly, 
after 4 days of antibiotic pre-treatment (2 mg/mL streptomycin, 1 mg/mL bacitracin, and 0.1 mg/mL 
gentamycin) with or without aCT, 107 C. albicans cells were intragastrically inoculated in a single gavage 
dose. Stool samples were obtained on different days (indicated in the accompanying figures) and 
homogenized in PBS prior to be cultured in SD plates to determine CFUs per gram. 4 mice were used in 
each experiment and repeated at least twice; only a representative experiment is shown. To analyze 
C. albicans loads in the gastrointestinal tract, mice were sacrificed and intestinal content from stomach, 
cecum, small and large intestine were aseptically obtained, homogenized in sterile PBS and cultured in SD 
plates to count CFUs. Female mice C57BL/6 were purchased from Harlan Laboratories, Inc. (Italy) and used 
within an age of 7 to 10 weeks-old. Mice housing and other non-invasive procedures took place in the animal 
housing facility from the Medical School of the Universidad Complutense de Madrid. 
All experiments involving animals performed in this work were carried out in strict accordance with the 
regulations in the “Real Decreto 1201/2005, BOE 252” for the Care and Use of Laboratory Animals of the 
“Ministerio de la Presidencia,” Spain. The protocol used in the commensalism model was approved by the 
Animal Experimentation Committee of the University Complutense of Madrid (CEA 33-2015) and 
Comunidad de Madrid according to Artículo 34 del RD 53/2013 (PROEX 226/15). The treatments did not 
result in noticeable disease in the animals; nevertheless, all procedures were conducted minimizing any 
suffering. The number of animals per experiment was adjusted to a minimum for ethical reasons. 
Experiments were done at least twice and only one representative experiment is shown in the Figures. 
Adhesion assays 
Adhesion to the intestinal mucosa was assessed as previously described [13]. Briefly, a 1 cm-piece of the 
large intestine of a non-colonized euthanized mouse was opened, washed gently with PBS and placed in a 
4 mm-diameter methacrylate chamber made of two different sheets of methacrylate joined by clamps. The 
chamber was immediately filled with RPMI medium pre-warmed at 37°C. Then, two C. albicans strains (from 
overnight YPD cultures) to be tested were mixed (1:1 ratio) and adjusted to 2x106 cells/mL concentration in 
serum-free RPMI medium. 105 yeast cells from this suspension were placed facing the original lumen of the 
colonic tissue in the chamber and incubated for 150 min at 37°C. After this period, the piece of tissue was 
carefully washed twice with PBS and mechanically disaggregated. Serial dilutions of this last fraction was 
spread on SD media for CFUs determination. Three similar (size, region) pieces of colonic tissue were used 
for each competitive determination. 
An internal control (CAF2-GFP [13]) was introduced in all adhesion assays; therefore, adherence is 
quantified by the adhesion relative index (ARI). This index is calculated by dividing the relative amounts of 
the strain under analysis in adhered cells relative to the value of that same strain in the inoculum and 
therefore reflects the adhesion relative to the parental CAF2-GFP strain. 
Statistical analysis 
Statistical differences were assessed with the SPSS Software (UCM, Madrid, Spain). A p < 0.05 was 
considered significant using ANOVA tests (followed by Dunett’s multiple comparisons test). 
Results 
Development of a filamentation - regulatable strain by tetracyclines 
In order to analyse the role of the yeast-to-hypha transition, we constructed a strain in which the TUP1 gene 
is under the control of the tetracycline repressible version (TET-OFF). For this purpose, the TUP1 coding 
region was cloned in the pNRU plasmid (see Material and Methods), which also tagged the protein with a 
c-terminal myc epitope, and the gene reporter RFP (dTOM2) in the pDS2 plasmid. The constructs were 
integrated in a tup1 mutant generating the TUP1REP-RFPREP strain. To confirm the conditional expression 
system, we analysed TUP1 function by observation of the expected filamentous characteristic phenotype of 
tup1 mutants in the TUP1REP -RFPREP strain both in liquid and solid media. Under normal conditions (YPD 
without antibiotic), only yeast cells were observed (Figure 1A). However, the addition of doxycycline to the 
medium induced the filamentation due to the repression of TUP1 and wrinkled colonies appeared on solid 
agar plates. In both cases, the wild type CAF2 strain showed the corresponding yeast phenotype while a 
homozygous tup1 mutant remained permanently blocked in the filament form. 
Due to the broad antibacterial spectrum of doxycycline and its potential effect on mice microbiota during in 
vivo experiments, which could interfere with the results, we tested a heat inactivated variant of tetracycline 
(autoclaved chlortetracycline, aCT) [13, 25]. To validate the use of aCT in colonization experiments, we 
determined in vitro its antimicrobial activity (as determined by CMI measures) against E. coli DH5α strain 
compared to the non-inactivated doxycycline. aCT resulted in a 30x fold reduction in its CMI compared to 
non-inactivated doxycycline (1.5 mg/L vs 50 mg/L) (data not shown). On the other hand, aCT efficiently 
repressed TUP1 expression in TUP1REP-RFPREP strain similarly to doxycycline, since both compounds 
showed the same efficiency in inducing filamentation (via TUP1 repression) when concentration reaches 
0.05 mg/L where hyphae and pseudohyphae were detected (Figure 1B).  
We also analysed if this effect was due to the repression of TUP1. We studied the ability of aCT and 
doxycycline to repress TUP1 by western blot (Figure 1C). In the absence of antibiotic, a clear band of Tup1-
myc with the expected molecular weight of 59 kDa appeared while no band was observed when antibiotic 
(> 0.05 mg/L) was added to the medium indicating the tight regulation of both compounds.  
Role of TUP1-mediated filamentation in mice gut colonization 
The ability of aCT to regulate cellular morphology via TUP1 enabled us to determine the contribution of the 
filamentous form in the colonization of mice gut. To validate aCT as a tool to regulate gene expression in 
vivo without alteration in the gut fitness, we analyse aCT bioavailability and activity along mouse intestine. 
aCT 1 g/L was incorporated in the drinking water of mice for 7 days;  the animals were then sacrificed and 
intestinal samples were used in a bioassay for aCT quantification in vitro (Figure 2A). Intestinal samples 
from aCT-treated or not mice were homogenized in PBS and 10 fold diluted in YPD, media that was used 
to grow the TUP1REP-RFPREP strain for 16 hours at 37 ºC. We observed that filaments were present only in 
samples from aCT-treated mice, while this morphology was absent in standard-antibiotic-treated mice (non-
aCT-treated), suggesting that the addition of 1 g/L aCT in the drinking water is enough to induce 
filamentation of the TUP1REP -RFPREP strain in the mouse intestine.  
We next analysed the role of filamentation during colonization. After four days of antibiotic treatment (2 g/L 
streptomycin, 1 g/L bacitracin and 0.1 g/L gentamicin) in drinking water, 107 C. albicans cells of the 
TUP1REP-RFPREP strain were inoculated in a single dose by gavage and fecal samples were analysed. As 
we can observed in Figure 2B, in the first 7 days  TUP1REP-RFPREP strain colonized similarly to the wt CAF2 
strain (≈107 CFUs/g), as previously described [13]. After this period, the TUP1REP-RFPREP colonization levels 
dropped to ≈105 CFUs/g and were maintained until the end of the experiment (≈20 days). At day 20, aCT 
was administered in drinking water which led to a significant drop in colonization levels (≈103 CFU/g, Figure 
2B). Colonization was lost in 5-10 days after the administration of aCT. No CFUs were detected in post-
mortem analysis of mice, indicating the complete disappearance of the cells in the luminal cavity. These 
results suggest that the filamentous form is less efficient in gut colonization. When aCT was administered 
from the beginning of the colonization experiment and before C. albicans inoculation, the TUP1REP-RFPREP 
strain showed a clear decrease and the colonization ratios began to decrease from day 1 until its complete 
disappearance (Figure 2C), and no candida cells were detected in post-mortem analysis of the mice. 
Collectively, we conclude that the blockage in a filamentous growth due to TUP1 repression impairs 
C. albicans to colonize and maintains in the mice gut.  
Sensitivity to bile salts and adhesion to the intestine 
Different reasons have been proposed to be the cause for the impairment of gut colonization, such as 
susceptibility to bile salts or adhesion to the gut mucosa [13]. Sensitivity to bile salts, present in the small 
intestine, has been proposed as a potential cause to the defects in fitness of candida strains within the gut. 
For this reason, we performed a drop susceptibility assay with exponentially growing cells of the TUP1REP-
RFPREP growing in the presence or absence of aCT to allow yeast and filament forms respectively. However, 
no significant differences were found compared to the wild type CAF2 strain nor to the filamentation status 
due to the presence or absent of aCT (Figure 3A).  
We also tested the adhesion to the gut mucosa in a competitive ex vivo assay, as previously described [13]. 
Similar proportions of TUP1REP-RFPREP, growing in the absence or presence of aCT, and a CAF2-GFP wt 
strain growing in the same conditions (used as internal control) were mixed and incubated with intestinal 
mucosa. After 150 minutes, fungal cells were recovered and the relative proportions of both cells type 
relative to the inoculum was determined as described in Material and Methods. We observed, that the 
induction of filamentation (+aCT) reduced adhesion from 1.25 ± 0.12 (mean) to 1.05 ± 0.18, although these 
differences were not statistically significant (Figure 3B).  
These results suggest that neither sensibility to bile salt nor adhesion to the gut epithelium explain the 
defects in colonization associated to TUP1-mediated filamentation.  
Discussion 
The controversy on the role of morphology in the virulence of C. albicans sustained in the past an intense 
debate in the mycology field [26-28]. While mutants unable to filament were frequently avirulent in certain 
animal models [15], it soon became evident that certain hyperfilamentous mutants or strains locked in the 
filamentous form were also avirulent [16, 21]. The development of genetics soon enabled the construction 
of strains where hyphal formation could be either triggered or repressed in vivo. These tools demonstrated 
that hyphal conversion is important for virulence but, more importantly, that ability to alternate between 
different morphologies was indeed essential for the fungus to cause disease [18]; differences were 
appreciated between both morphologies and yeast forms were found to colonize more abundantly target 
organs in the standard mouse systemic model of infection [29]. As the gastrointestinal location may be an 
important source of endogenous infections [30, 31], understanding the mechanisms underlying 
colonization is essential for the design of efficient prophylactic and therapeutic strategies [11]. In fact, 
those factors impeding colonization may be relevant strategies to prevent candidiasis.  
We have analysed the role of filamentation in commensalism using a TUP1-regulated strain where the 
addition of doxycycline efficiently leads to filamentation. We first validated the use of this drug in in vivo 
studies, as doxycycline, a broad spectrum antibacterial used in C. albicans genetics [32] could significantly 
alter the microbiota of colonized mice. Our data indicate that heat inactivated chlortetracycline (aCT) is as 
efficient as doxycycline in repressing TUP1 expression. We demonstrate that the TUP1REP-RFPREP strain 
was indeed able to colonize the mouse gut: initial fungal loads in the gut were ≈107 CFU/g but dropped to 
≈105 after one week and remained constant onwards.  
In this model, induction of filamentation due to TUP1 repression led to a complete loss of C. albicans cells 
in the gut. This result is in agreement with recent data that indicate that filamentous locked strains (nrg1∆) 
colonized less efficiently the mouse [19]. However, one important feature of our results is that we 
introduce cells in the mouse in the yeast form and trigger filamentation inside the host, thus discarding the 
possibility (not addressed in the mentioned work) that that filamentous forms would be able to colonize 
once in the intestine but unable to initiate it. This may be relevant as different adaptation phases can be 
detected when colonizing the mouse gut in this particular commensal model [20]. We still have no 
explanation for this behaviour; susceptibility to bile salts influences initial colonization loads achieved [33] 
but no major changes were detected between wt and TUP1REP-RFPREP cells. Transcriptomic analysis of 
tup1 cells reveals changes in several metabolic traits that could be relevant during adaptation to the gut 
environment, mainly anaerobic [34] but they are obtained from in vitro cultured cells. Adhesion to the gut 
epithelium may be also relevant in the context of colonization, as several adhesins are either present or 
absent in tup1 mutants. It may be as well that the filamentous form is intrinsically less efficient in 
colonizing due to a mere mechanical reasons (and more efficient removal natural flow of the aliments in 
the lumen). Our results are in agreement with recent results obtained using germ free mice [35]. These 
authors identified different C. albicans genes (ZFY2, ZCF8, ZFU2 and TRY4) whose deletion resulted in 
enhanced filamentation and reduced colonization. In addition, expression of the UME6 filamentation 
regulator had a similar effect. As these experiments were obtained with germ free mice, mice microbiota 
does not seem to influence the preference of yeast versus filaments in the mouse lumen. The reasons for 
this may be speculative at this stage but a different immune response, resistance to innate antifungal 
mechanisms, adherence to the lumen or even simple mechanical features may be responsible for this 
effect. Therefore, our work supports that the C. albicans yeast form is more prone to colonize than 
hyphae. Importantly, our results reinforce the concept that induction of filamentation of C. albicans in the 
human gut via drugs or food products may be an alternative approach to reduce colonization and minimize 
systemic fungal infections caused by this yeast. 
Conclusions 
The work presented here show that induction of filamentation via TUP1 repression results in a loss of 
C. albicans cells within the mouse gut, while the corresponding yeast forms efficiently colonizes at lower 
levels. These effects are not due to a defect in adhesion to the gut epithelium nor to an increased 
susceptibility to bile salt suggesting that filamentous forms are intrinsically less adapted to grow in the 
mammalian intestines. 
Summary Points 
TUP1 repression led to a filament locked phenotype both in liquid and solid media 
Autoclaved chlortetracycline, aCT, has a reduced antimicrobial effect but is still able to regulate the 
TETON/TETOFF regulatable system in Candida albicans 
TUP1 repression renders candida filament cells that are unable to establish in the murine gut 
The induction of filamentation by repressing TUP1 induced the loss of candida cells once stablished in the 
murine gut 
No differences in susceptibility to bile salt nor to the ability to adhere to the gut mucosa is due to the 
repression of TUP1 
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Figure 1. TUP1-myc regulation in regulated strains under the control of the TET-OFF system.   
A) Cellular morphology after 16 hours at 37ºC of growth in the absence (-) or presence of 20 mg/L 
doxycycline. An image from a drop assay on solid media with or without dox after 48 h growth is shown 
(inset); B) Cellular morphology of the TUP1REP-RFPREP strain in YPD supplemented with increasing 
concentration of dox after 16 hours of growth at 37ºC. C) Tup1-myc detection under different doxycycline 
(upper panel) or aCT (lower panel) concentrations in YEPD at 37ºC 
Figure 2. Filamentous forms are less efficient to colonize de GI tract 
A) Bioassay to detect the aCT presence in mice intestine. Cellular morphology of the TUP1REP-RFPREP strain 
in the presence of the intestine content from mice treated or not with aCT after 16 hours of growth at 37 ºC., 
B) TUP1REP-RFPREP colonization rates expressed as logarithmic values of the CFUs per gram of stool along 
the time in mice treated with standard antibiotic treatment. At day 20 aCT 1 g/L was added to the drinking 
water; C) TUP1REP-RFPREP colonization rates in mice treated with standard antibiotic cocktail plus aCT 1 g/L 
from the beginning of the experiment.  
Figure 3. Analysis of bile salt sensitivity and adhesion to mouse mucosa 
A) Tenfold serial dilutions of overnight growing cultures from the indicated strains were spotted in YPD plates 
supplemented or not with bile salts in the presence or not of aCT 20 mg/L; B) The adhesion relative index 
(ARI) was determined for the TUP1REP-RFPREP in the large intestine in the presence or absence of aCT. 
Individual values are shown with the mean ± SEM.  
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